Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

SERNOVA CORP V.SVA

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  SEOVF

Sernova Corp is a clinical stage biotechnology company. It is engaged in the research and development of a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases.
Price: $0.20 | Change: $-0.005 | %Change: -2.44%
Volume: 345,895 | Day High/Low: 0.22/0.20 | 52 Week High/Low: 0.34/0.10

Snapshot

Last Traded: September 16, 2014 11:59 Transaction Volume: 345,895
Open: $0.20 Previous Close: $0.205
Bid: $0.185 Ask: $0.20
Bid Size: 15,000 Ask Size: 152,000
Market Cap: $26.2m Shares Out: 130.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   May 16, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Progress update on Sernova and N.A. Nickel

Sernova’s product focus is on treating insulin-dependent diabetes. NAN is focused on greenfields nickel exploration.

Richard (Rick) Mills   July 17, 2012
0 stars

Latest Bullboard Posts